A federal judge Tuesday dropped some charges against Theranos founder Elizabeth Holmes, but let stand wire fraud charges accusing her and an associate of deceptive patients in regards to the abilities of her firm’s blood tests.
The court required that since their medical insurance coverage corporations paid the tests, the sufferers weren’t deprived of any money or property in taking Theranos blood testing services.
It further stated there was no evidence to show that Holmes and the company’s former president Ramesh Balwani directed doctors to make parodies to their patients.
Based on the warrant, Holmes and Balwani encouraged doctors and sufferers to make use of the company’s blood-testing services. However, they knew Theranos was not able to persistently produce correct and reliable results for particular blood tests.
Holmes and Balwani had been indicted in June 2018 on 11 counts of conspiracy and wire fraud. They have pleaded not guilty.
Holmes, a Stanford University dropout, began Theranos at age 19. Questions had been first raised about the accuracy and reliability of the corporate’s trademark blood-testing device in a collection of articles in 2015.